Nikkei Spotlights South Korea's "Sushijaro"
5,030 Illegal Import Cases Detected Through August

The number of South Koreans seeking to buy the obesity drug Mounjaro cheaply in Japan and bring it back to South Korea is surging. As cross-border purchases spread, cases of illegal importation have also increased.


On October 8, Japan's Nihon Keizai Shimbun (Nikkei) reported that the number of South Korean tourists buying Mounjaro in Japan is rising amid a sharp increase in cases of the diabetes and obesity drug being illegally brought into South Korea.


The photo is unrelated to a specific expression in the article. Getty Images Bank.

The photo is unrelated to a specific expression in the article. Getty Images Bank.

View original image

Japan Cut Mounjaro's Price in August

Nikkei reported that a new slang term, "Sushijaro," combining Mounjaro with sushi, has emerged to describe Mounjaro bought in Japan. It also said that Japanese medical institutions where patients can obtain Mounjaro prescriptions at low cost are being called "pilgrimage sites," with related information shared on social media. One buyer said, "Even including round-trip airfare and accommodation, buying it in Japan is much cheaper."


The main reason South Koreans buy Mounjaro in Japan is the price difference. A one-month supply of the lowest dose, 2.5 mg, costs about 10,000 yen (approximately 84,000 won) in Japan, compared with 280,000 to 350,000 won in South Korea.


In August 2026, Japan's Ministry of Health, Labour and Welfare cut Mounjaro's price by 25% to reduce medical costs. The price in Japan fell further as a result, and more South Korean tourists seeking cheaper Mounjaro are bringing back medication prescribed at Japanese medical institutions.

Sharp Rise in Illegal Imports of Obesity Drugs

However, bringing Mounjaro into South Korea is illegal without approval from South Korea's Ministry of Food and Drug Safety, even if it was prescribed by a licensed medical institution overseas. The Korea Customs Service is also cracking down, including by stepping up inspections during customs clearance. According to the agency, the number of cases in which Mounjaro and other obesity drugs such as Wegovy were seized for illegal importation rose sharply, from four in all of 2024 to 5,030 through August 2026.


In South Korea, health insurance does not cover Mounjaro when it is used to treat obesity, so patients must pay the full cost themselves. Because medical institutions can set their own prices for services not covered by insurance, prices can easily become high amid strong demand for cosmetic and weight-loss treatments.


According to data submitted by the Health Insurance Review and Assessment Service to Han Ji-a, a lawmaker from the People Power Party, more than 1.5 million Mounjaro prescriptions were issued in South Korea over the 10 months from August 2025 through May 2026. People in their 20s and 30s accounted for more than half of the prescriptions, and prescriptions for teenagers have also been increasing recently.


Obesity drugs such as Mounjaro are used to treat patients with obesity who meet certain body mass index (BMI) criteria, as well as patients with type 2 diabetes. However, concerns about misuse are growing as more people use them for cosmetic purposes and weight loss.


Yonhap News Agency

Yonhap News Agency

View original image

In a survey conducted by the Korea Disease Control and Prevention Agency in 2025, 68.5% of adults said they were trying to lose weight or maintain their weight. The desire to lose weight was particularly strong among young women. According to the agency, 16.2% of women aged 19 to 29 who were underweight, with a BMI below 18.5, were dieting, while more than half of women at a normal weight were also trying to lose weight.


Nikkei noted that a trend favoring celebrities' excessively thin physiques is spreading in South Korea, where the slang term "Ppyeomalla," meaning a body so thin that the bones are visible, has emerged. It also reported that many young people are influenced by information they encounter on social media and follow extreme diets promising dramatic weight-loss results.



There are also concerns that if bulk purchases of Mounjaro in Japan become more widespread, there may not be enough of the drug for patients who genuinely need treatment. Japan's Ministry of Health, Labour and Welfare is urging the appropriate use of Mounjaro.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing